Imprimis Pharmaceuticals Registers its New Jersey Facility with the ...

Satellite PR News (press release)-1 hour ago

Section 503B of the new law allows outsourcing facilities to register with and submit to inspection by the FDA, produce certain finished compounded drugs to ...